Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Arlene Chan

18PUBLICATIONS

81CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHealth and ecological risk assessmentInnate immunity

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|Dec 29, 2025

OPERA-01: a phase III study of palazestrant for ER+, HER2- advanced breast cancer after CDK4/6 inhibitor therapy.

Barbara Pistilli, Meritxell Bellet Ezquerra, Lucia Del Mastro

|Apr 10, 2025

Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies.

José A García-Saenz, Gonzalo Spera, Marina Pollán

|Feb 28, 2025

Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial.

Peter A Fasching, Dennis Slamon, Zbigniew Nowecki

|Dec 06, 2024

Influence of Epithelial-Mesenchymal Transition on Risk of Relapse and Outcome to Eribulin or Cyclin-Dependent Kinase Inhibitors in Metastatic Breast Cancer.

Arlene Chan, Jespal Gill, HuiJun Chih

|Jun 22, 2023

AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.

Sara M Tolaney, Arlene Chan, Katarina Petrakova

|Feb 08, 2023

Prognostic role of immune environment in luminal B early breast cancer.

Arlene Chan, Jespal Gill, HuiJun Chih

Pageof 3

Frequent Collaborators

2 joint publications

Hope S Rugo

2 joint publications

Christopher Lomma

2 joint publications

Zbigniew Nowecki

2 joint publications

Miguel Martin

2 joint publications

Seock-Ah Im

1 joint publications

Fiona McDonald

1 joint publications

Naomi Brook

1 joint publications

Heather McArthur

1 joint publications

Crispin R Dass

1 joint publications

Ahmad Awada

Frequent Collaborators

2 joint publications

Hope S Rugo

2 joint publications

Christopher Lomma

2 joint publications

Zbigniew Nowecki

2 joint publications

Miguel Martin

Top Related Videos

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs

Published on : Dec 16, 2022

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on : Feb 06, 2020

See more related videos

Top Related Videos

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs

Published on : Dec 16, 2022

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on : Feb 06, 2020

See more related videos